Head-to-head · Value Score
Vitara RX vs Lumora
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Lumora a 63. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameLumora
#334 · Grade C · Watch List
Est. first month
From $199/mo (starting dose, plus a separate fee, compounded)
Save ~85% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 63 — an est. $99/mo first month, with no teaser step-up baked in. Lumora isn't out of it: Shoppers who want adults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | Lumora |
|---|---|---|
| Value Score | 91 (A) | 63 (C) |
| Est. first month | $99/mo | From $199/mo (starting dose, plus a separate fee, compounded) |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | From $199/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $149/mo | From $299/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
Lumora
Lumora (Blue Skies MD LLC dba Lumora MD) is a physician-founded telehealth platform offering compounded semaglutide and tirzepatide in injectable and sublingual forms.
Why it's a deal
- Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
- Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
- LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
- Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
- Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141
The fine print
- Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
- Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
- Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
- No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
- Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Lumora.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.